Loading organizations...
Based in Washington, DC, GMS Capital Partners is an investment management firm that sources and executes transactions across private equity, venture capital, real estate, and alternative assets on behalf of its parent company, GMS Holdings. The firm supports its portfolio companies by providing strategic expertise in corporate board management, operational scaling, and long-term value creation. GMS Capital Partners holds board roles at organizations such as Outlook Therapeutics and Jordan Ahli Bank, while its leadership team brings prior experience advising on over $100 billion in mergers and acquisitions. In the venture capital space, the firm recently participated in a $5.25 million Series A funding round for Egyptian healthtech startup Chefaa, investing alongside Global Brain. Operating as a dedicated investment vehicle, GMS Capital Partners was established in 2017 and is currently led by Chief Executive Officer Yezan Haddadin.
GMS Capital Partners has 3 tracked investments across 3 companies. The latest tracked deal is $9.2M Debt / Series B in Compass in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 9, 2026 | Compass | $9.2M Debt / Series B | Oriental Land Innovations | Gougin Capital, M3, Mizuho Bank, Shizuoka Capital |
| Feb 23, 2026 | Ubicquia | $106.0M Series D | Cort AHL, Ichiro Miyoshi | ClearSky, Hamilton Lane, Sercomm |
| Apr 13, 2021 | CeQur Simplicity | $115.0M Other Equity | Credit Suisse, Endeavour Vision | Federated Kaufmann Fund, Kingdon Capital, Schroders, John F. Sheridan, VI Partners, Ypsomed Group |
